Premium
Allergic contact dermatitis caused by transdermal buprenorphine
Author(s) -
Kyrklund Carl,
Hyry Heli,
Alanko Kristiina
Publication year - 2013
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/cod.12051
Subject(s) - medicine , allergy , dermatology , allergic contact dermatitis , university hospital , drug allergy , atopic dermatitis , surgery , immunology
Buprenorphine is a potent semisynthetic opioid analgesic that is widely used to treat moderate to severe pain. Since 2001, it has been available in several European countries in a transdermal delivery system (TDS), and it was approved for use in the United States in 2010. We report 3 cases of allergic contact dermatitis caused by a TDS containing buprenorphine, as verified by a positive patch test reaction.